Autor: |
Dong Hyun Lee, Ji Hye Min, Sang Byung Bae, Hyo Wook Gil, Jong Oh Yang, Eun Young Lee, Sae Yong Hong |
Jazyk: |
English<br />Korean |
Rok vydání: |
2015 |
Předmět: |
|
Zdroj: |
Kidney Research and Clinical Practice, Vol 34, Iss 1, Pp 60-63 (2015) |
Druh dokumentu: |
article |
ISSN: |
2211-9132 |
DOI: |
10.1016/j.krcp.2014.09.004 |
Popis: |
A 78-year-old man on hemodialysis presented to our hospital with erythrocytosis. He had started hemodialysis 4 years previously, with a hemoglobin level of 9.8 g/dL, and was administered erythropoiesis stimulating agents and ferrous sulfate. Two years previously, his hemoglobin level increased to 14.5 g/dL and the treatment for anemia was discontinued. He continued hemodialysis thrice weekly; however, the hemoglobin level had increased to 17.0 g/dL at the time of presenting to our hospital. His serum erythropoietin level was 31.4 mIU/mL (range, 3.7–31.5 mIU/mL), carboxyhemoglobin level was 0.6% (range, 0–1.5%), and oxygen saturation in ambient air was 95.4%. The JAK2 V617F mutation was not observed and other bone marrow abnormalities were not identified. The patient was diagnosed with bladder cancer and a transurethral resection was performed. Eight months after the treatment of bladder cancer, his hemoglobin level was 15.1 g/dL, and he was diagnosed with idiopathic erythrocytosis. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|